Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1
Clinical trial NCT00784147 · COMPLETED
Trial details
- NCT number
- NCT00784147
- Sponsor
- TaiMed Biologics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2011-04-01
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.